Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07686393 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PET Imaging of Noradrenergic Transmission in the Brain

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Eligibility criteria expanded, about 19 words
  3. Minor Re-verified, no change to tracked fieldsv33
  4. Minor Start date changed from estimate of Aug 23, 2026 to Aug 14, 2026v32
  5. Minor Start date: Aug 20, 2026 to Aug 23, 2026v31
Show 29 earlier versionsHide 29 earlier versions
  1. Minor Start date: Aug 19, 2026 to Aug 20, 2026v30
  2. Minor Start date: Aug 18, 2026 to Aug 19, 2026v29
  3. Minor Start date: Aug 17, 2026 to Aug 18, 2026v28
  4. Minor Start date: Aug 16, 2026 to Aug 17, 2026v27
  5. Minor Start date: Aug 13, 2026 to Aug 16, 2026v26
  6. Minor Start date: Aug 12, 2026 to Aug 13, 2026v25
  7. Minor Start date: Aug 11, 2026 to Aug 12, 2026v24
  8. Minor Start date: Aug 10, 2026 to Aug 11, 2026v23
  9. Minor Start date: Aug 7, 2026 to Aug 10, 2026v22
  10. Minor Start date: Aug 6, 2026 to Aug 7, 2026v21
  11. Minor Start date: Aug 5, 2026 to Aug 6, 2026v20
  12. Minor Start date: Aug 4, 2026 to Aug 5, 2026v19
  13. Minor Start date: Aug 3, 2026 to Aug 4, 2026v18
  14. Minor Start date: Aug 2, 2026 to Aug 3, 2026v17
  15. Minor Start date: Jul 30, 2026 to Aug 2, 2026v16
  16. Minor Start date: Jul 29, 2026 to Jul 30, 2026v15
  17. Minor Start date: Jul 28, 2026 to Jul 29, 2026v14
  18. Minor Start date: Jul 27, 2026 to Jul 28, 2026v13
  19. Minor Start date: Jul 26, 2026 to Jul 27, 2026v12
  20. Minor Start date: Jul 23, 2026 to Jul 26, 2026v11
  21. Minor Start date: Jul 22, 2026 to Jul 23, 2026v10
  22. Minor Start date: Jul 21, 2026 to Jul 22, 2026v9
  23. Minor Start date: Jul 20, 2026 to Jul 21, 2026v8
  24. Minor Start date: Jul 19, 2026 to Jul 20, 2026v7
  25. Minor Start date: Jul 16, 2026 to Jul 19, 2026v6
  26. Minor Start date: Jul 15, 2026 to Jul 16, 2026v5
  27. Minor Start date: Jul 14, 2026 to Jul 15, 2026v4
  28. Minor Start date: Jul 13, 2026 to Jul 14, 2026v3
  29. Minor Start date: Jul 12, 2026 to Jul 13, 2026v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Researchers have developed a new radioactive tracer (11C-ARMI). A tracer is a drug that attaches itself to other chemicals in the body and lights up so that the chemicals can be seen in imaging scans. The new tracer may be able to help them with many diseases, such as Alzheimer s disease and Parkinson s disease. Researchers want to test the new tracer in healthy people. Objective: To test a new tracer (11C-ARMI) during imaging scans of the brain and body in healthy people. Eligibility: Healthy people aged 18 years and older. They must have been screened under protocols 01-M-0254 or 17M0181. Design: All participants will have a positron emission tomography (PET)/computed tomography (CT) scan. Before the scan, they will have blood and urine tests and a test of their heart function. The tracer will be given through a tube attached to a needle inserted into a vein in the arm. They will lie on a padded bed that fits inside a doughnut-shaped machine; the machine uses x-rays to create images of the inside of the body. Some participants will have a PET/CT scan of their whole body. They will need only 1 visit. Some participants will have a PET/CT scan of only their brain. They will have up to 2 visits. On the second visit, they will have a magnetic resonance imaging (MRI) scan of the brain. For the MRI, they will lie on a table that slides into a cylinder. The MRI uses magnetic fields to create images of the inside of the body. Participants will receive a follow-up call to check on their well-being after their PET/CT scans.
Trial Details
NCT Number NCT07686393
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Healthy
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov